Cannabidiol for at risk for psychosis youth: A randomized controlled trial-Reference-Cited by-同舟云学术

Cannabidiol for at risk for psychosis youth: A randomized controlled trial

Published:2021-06-30 Issue: Volume: Page:
ISSN:1751-7885
Container-title:Early Intervention in Psychiatry
language:en
Short-container-title:Early Intervention in Psychiatry

Author:

Amminger G. Paul¹²^ORCID,Lin Ashleigh³^ORCID,Kerr Melissa¹²,Weller Amber¹²,Spark Jessica¹²^ORCID,Pugh Charlotte³,O'Callaghan Sally¹²,Berger Maximus¹²,Clark Scott R.⁴,Scott James G.⁵⁶⁷,Baker Andrea⁵⁶,McGregor Iain⁸,Cotter David⁹,Sarnyai Zoltan¹⁰,Thompson Andrew¹²,Yung Alison R.¹²¹¹,O'Donoghue Brian¹²^ORCID,Killackey Eoin¹²,Mihalopoulos Cathy¹²,Yuen Hok Pan¹²,Nelson Barnaby¹²,McGorry Patrick D.¹²

Affiliation:

1. Orygen Melbourne Australia

2. The Centre for Youth Mental Health The University of Melbourne Melbourne Australia

3. Telethon Kids Institute, The University of Western Australia Perth Australia

4. Discipline of Psychiatry, University of Adelaide Adelaide Australia

5. QIMR Berghofer Medical Research Institute Brisbane Australia

6. Queensland Centre for Mental Health Research, The Park Centre for Mental Health Brisbane Australia

7. Metro North Mental Health Service Herston Australia

8. Lambert Initiative for Cannabinoid Therapeutics, University of Sydney Sydney Australia

9. Royal College of Surgeons Dublin Ireland

10. James Cook University Townsville Australia

11. School of Health Science, University of Manchester Manchester UK